Women who have had early stage breast cancer surgically removed, and whose tumour cells are stimulated by the hormone oestrogen, can benefit from taking Luteinizing hormone releasing hormone (LHRH) antagonists, a Cochrane Systematic Review has concluded. This medication may be taken alone or alongside the use of tamoxifen. Developing effective treatment regimes is important because approximately 30% of women diagnosed with early stage breast cancer eventually die of the disease.
More...